Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Leukemia

Free Subscription 07.07.2025 1 Am J Hematol 4 Ann Hematol 2 Blood 1 Cancer 3 Eur J Haematol 1 Exp Hematol 1 Hematol Oncol Clin North Am 1 Int J Hematol 1 Leuk Lymphoma 4 Leukemia 1 Oncol Rep 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Hematol

1. ADRIANO V, Michal K, Ernesta A, Mario L, et al
   MRD Assessment in Patients With Acute Myeloid Leukemia Aged >/= 60 Years Treated With a 10-Day Decitabine Schedule Versus Intensive Chemotherapy in the AML21 Study.
   Am J Hematol. 2025 Jul 1. doi: 10.1002/ajh.27763.
   PubMed        
   
   

   
   Ann Hematol

2. ZIELINSKA P, Gruenpeter K, Wieczorkiewicz-Kabut A, Bialas K, et al
   Second allogeneic transplantation in relapsed acute leukemia - a risk worth taking?
   Ann Hematol. 2025 Jul 3. doi: 10.1007/s00277-025-06468.
   PubMed         Abstract available
   
   
3. IZUMI A, Tachibana T, Nukui J, Miyazaki T, et al
   Clinical significance of C-reactive protein/platelet ratio from diagnosis to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
   Ann Hematol. 2025 Jul 3. doi: 10.1007/s00277-025-06470.
   PubMed         Abstract available
   
   
4. CHEN X, Yuan L, Ma X, Wang F, et al
   TRAF3IP3::FGFR1: a novel FGFR1 fusion identified in an aggressive case of acute myeloid leukemia.
   Ann Hematol. 2025 Jul 1. doi: 10.1007/s00277-025-06494.
   PubMed        
   
   
5. CHEN X, Ren Y, Jin Y, Li X, et al
   First report of B-lymphoblastic leukemia harboring LRRFIP1::FGFR1 fusion: expanding the clinical spectrum of myeloid/lymphoid neoplasms with tyrosine kinase gene fusions.
   Ann Hematol. 2025 Jun 30. doi: 10.1007/s00277-025-06481.
   PubMed        
   
   

   
   Blood

6. CARTER BZ, Mak PY, Ayoub E, Wu X, et al
   Restoring p53 wild-type conformation in TP53-Y220C-mutant acute myeloid leukemia.
   Blood. 2025 Jul 3:blood.2025028935. doi: 10.1182/blood.2025028935.
   PubMed         Abstract available
   
   
7. MOHAMED A, Richardson AI
   Therapy-related juvenile myelomonocytic leukemia.
   Blood. 2025;146:127.
   PubMed        
   
   

   
   Cancer

8. GIAI V, Rosso T, Castagnetti F, Pregno P, et al
   Chronic myeloid leukemia outcomes according to baseline risk and first-line treatment in real-world settings: Data from the Italian Network/CML Campus.
   Cancer. 2025;131:e35963.
   PubMed         Abstract available
   
   

   
   Eur J Haematol

9. LAGANA A, Scalzulli E, Carmosino I, Bisegna ML, et al
   Treatment Free Remission (TFR) in Chronic Phase-Chronic Myeloid Leukemia (CP-CML): Analysis of Predictive Factors and Novel Baseline Scoring System to Predict Molecular Relapse.
   Eur J Haematol. 2025 Jun 30. doi: 10.1111/ejh.70006.
   PubMed         Abstract available
   
   
10. FENWARTH L, Podvin B, Vasseur L, Lebon D, et al
    Myeloid Neoplasms With Erythroid Predominance and Excess Blasts in Young Adults Exhibit Distinct Genetic Profiles.
    Eur J Haematol. 2025;115:185-192.
    PubMed         Abstract available
    
    
11. BAHRAMI HEZAVEH E, Yan J, Zhao D, Wangulu C, et al
    Genetic Landscape and Risk Stratification of AML With Hyperdiploid Karyotype.
    Eur J Haematol. 2025;115:165-175.
    PubMed         Abstract available
    
    

    
    Exp Hematol

12. FOSSELTEDER J, Brauchart T, Schlacher A, Sconocchia T, et al
    Engineered cytokine-expressing MSCs support ex vivo culture of human HSPCs and AML cells.
    Exp Hematol. 2025;147:104790.
    PubMed         Abstract available
    
    

    
    Hematol Oncol Clin North Am

13. VITALE C, Ferrario A, Zamprogna G, Coscia M, et al
    Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.
    Hematol Oncol Clin North Am. 2025 Jun 30:S0889-8588(25)00064.
    PubMed         Abstract available
    
    

    
    Int J Hematol

14. UYGUN A, Albayrak C, Ozgen U, Dincer OS, et al
    The role of leukapheresis in managing complications of hyperleukocytosis in pediatric acute leukemia.
    Int J Hematol. 2025 Jun 30. doi: 10.1007/s12185-025-04027.
    PubMed         Abstract available
    
    

    
    Leuk Lymphoma

15. GULLAKSEN SE, Omsland M, Brevik M, Letzner J, et al
    CML stem cells and their interactions and adaptations to tyrosine kinase inhibitors.
    Leuk Lymphoma. 2025;66:1211-1220.
    PubMed         Abstract available
    
    

    
    Leukemia

16. RONNACKER J, Ruhnke L, Rollig C, Middeke JM, et al
    Induction chemotherapy with CPX-351 in acute myeloid leukemia: revisiting the role of early bone marrow assessment.
    Leukemia. 2025 Jul 3. doi: 10.1038/s41375-025-02675.
    PubMed        
    
    
17. GONG X, Liu W, Liu Y, Fang Q, et al
    Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trial.
    Leukemia. 2025 Jun 30. doi: 10.1038/s41375-025-02674.
    PubMed         Abstract available
    
    
18. WANG M, Zhu R, Small D, Lin L, et al
    SIRT5 inhibition impairs mitochondrial metabolism and enhances venetoclax-induced elimination of acute myeloid leukemia cells.
    Leukemia. 2025 Jun 30. doi: 10.1038/s41375-025-02673.
    PubMed         Abstract available
    
    
19. GAZEAU N, Beauvais D, Tilmont R, Srour M, et al
    Myeloid neoplasms after CD19-directed CAR T cells therapy in long-term B-cell lymphoma responders, a rising risk over time?
    Leukemia. 2025 Apr 24. doi: 10.1038/s41375-025-02605.
    PubMed         Abstract available
    
    

    
    Oncol Rep

20. CHEN N, Feng L, Qu H, Lu K, et al
    [Corrigendum] Overexpression of IL?9 induced by STAT3 phosphorylation is mediated by miR?155 and miR?21 in chronic lymphocytic leukemia.
    Oncol Rep. 2025;54:107.
    PubMed         Abstract available
    
    

    
    PLoS One

21. NAVIDINIA AA, Khayami R, Gholami A, Fathi M, et al
    Bioinformatics-guided construction of a tumor microenvironment-derived prognostic model in acute myeloid leukemia.
    PLoS One. 2025;20:e0325145.
    PubMed         Abstract available
    
    
22. BIEZUS G, Grima de Cristo T, Flores Koehler CM, de Quadros Kaveski FY, et al
    Survival analysis and clinical abnormalities in cats with progressive or regressive feline leukemia virus (FeLV) infection in Brazil.
    PLoS One. 2025;20:e0322691.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.